Viennese researchers: New hope for treatment of aggressive leukaemia

© Meduni Vienna

Up until now, the rare and highly aggressive form of blood cancer called T-PLL leukaemia could not be sufficiently treated in the past.

Scientists working at the Medical University of Vienna and the Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences have demonstrated  by means of high throughout screenings carried out on blood samples of patients with haematological diseases that the substance “venetoclax” is a successful therapy. This relatively new process functions by means of a robotic systems and is also efficient due to its rapid throughout.